KaydedilenlerDerginizi ekleyin

Dergiler / Diagnostic and Interventional Radiology / 2021 / Cilt: 27 - Sayı: 6

Role of magnetic resonance spectroscopy in differential diagnosis of solitary pulmonary lesions

Baki HEKİMOĞLU
Tuğba TAŞKIN TÜRKMENOĞLU
Azad HEKİMOĞLU
Onur ERGÜN
Aynur TURAN
Sayfa
710–715
Yayın Tarihi
2022-10-11
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION MRS is a noninvasive method that can be used in the differential diagnosis of pulmonary nodules and masses.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:PURPOSE The aim of our study was to evaluate the availability of magnetic resonance spectroscopy (MRS) for the differentiation of benign or malignant pulmonary nodules and masses.
📊
Temel Bulgular & Veri:METHODS A total of 59 patients (45 male, 14 female) with pulmonary nodules and masses were included in this prospective study.
💡
Sonuç & Katkı:CONCLUSION MRS is a noninvasive method that can be used in the differential diagnosis of pulmonary nodules and masses.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

PURPOSE The aim of our study was to evaluate the availability of magnetic resonance spectroscopy (MRS) for the differentiation of benign or malignant pulmonary nodules and masses. METHODS A total of 59 patients (45 male, 14 female) with pulmonary nodules and masses were included in this prospective study. MRS was applied to the pulmonary lesions of the patients and choline levels were determined. Afterwards CT-guided percutaneous needle biopsy was performed. According to the biopsy results, pulmonary lesions were benign in 25 patients and malignant in 34 patients. RESULTS Choline levels were significantly higher in malignant lesions compared with benign lesions (p 1.65 μmol/g compared to those with choline levels ≤1.65 μmol/g (p < 0.001). CONCLUSION MRS is a noninvasive method that can be used in the differential diagnosis of pulmonary nodules and masses.

🔖

Bu Makaleye Atıf Yap

HEKİMOĞLU, B., TÜRKMENOĞLU, T. T., HEKİMOĞLU, A., ERGÜN, O., TURAN, A. (2022). Role of magnetic resonance spectroscopy in differential diagnosis of solitary pulmonary lesions. Diagnostic and Interventional Radiology, Cilt: 27 - Sayı: 6, 710–715. https://ajindex.com/articles/487259

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Midthun DE, Swensen SJ, Jett JR. Approach to the solitary pulmonary nodule. Mayo Clin Proc 1993
  2. 378–385. [Crossref] 2. Lillington GA. Management of solitary pulmonary nodules: how to decide when resection is required. Postgrad Med 1997
  3. 145–150. [Crossref] 3. Brandman S, Ko JP. Pulmonary nodule detection, characterization, and management with multidetector computed tomography. J Thorac Imaging 2011
  4. 90–105. [Crossref] 4. Albert RH, Russell JJ. Evaluation of the solitary pulmonary nodule. Am Fam Physician 2009
  5. 827–831. 5. Pasławski M, Krzyzanowski K, Złomaniec J, Gwizdak J. Morphological characteristics of malignant solitary pulmonary nodules. Ann Univ Mariae Curie Sklodowska Med. 2004
  6. 6–13. 6. Murrmann GB, van Vollenhoven FH, Moodley L. Approach to a solid solitary pulmonary nodule in two different settings-"Common is common, rare is rare". J Thorac Dis 2014
  7. 237–248. 7. Lorenz J, Blum M. Complications of percutaneous chest biopsy. Semin Intervent Radiol 2006
  8. 188–193. [Crossref] 8. Manhire A, Charig M, Clelland C, et al. Guidelines for radiologically guided lung biopsy. Thorax 2003
  9. 920–936. [Crossref] 9. Noguerol TM, González JS, Barbero JPM, Figueiras RG, González BG, Luna A. Clinical imaging of tumor metabolism with 1H magnetic resonance spectroscopy. Magn Reson Imaging Clin N Am 2016
  10. 57–86. [Crossref] 10. Salibi N, Brown MA. Clinical MR spectroscopy. New York, NY: Wiley-Liss, 1998
  11. 20–22. 11. Lean C, Doran S, Somorjai RL, et al. Determination of grade and receptor sta¬tus from the primary breast lesion by magnetic resonance spectroscopy. Technol Cancer Res Treat 2004
  12. 551–556. [Crossref] 12. Khan SA, Cox IJ, Hamilton G, Thomas HC, Taylor-Robinson SD. In vivo and in vitro nuclear future directions of NMR magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of 1H and 31P MRS applications. Liver Int 2005
  13. 273–281. [Crossref] 13. Cho SG, Lee DH, Lee KY, et al. Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr 2005
  14. 163–169. [Crossref] 14. Verma S, Rajesh A, Fütterer JJ, et al. Prostate MRI and 3D MR Spectroscopy: How We Do It. AJR Am J Roentgenol 2010
  15. 1414–1426. [Crossref] 15. Chen W, Zu Y, Huang Q, et al. Study on metabonomic characteristics of human lung cancer using high resolution magic-angle spinning 1H NMR spectroscopy and multivariate data analysis. Magn Reson Med 2011